Cargando…

Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2

BACKGROUND: The COVID-19 pandemic is an infectious disease caused by SARS-CoV-2. The first step of SARS-CoV-2 infection is the recognition of angiotensin-converting enzyme 2 (ACE2) receptors by the receptor-binding domain (RBD) of the viral Spike (S) glycoprotein. Although the molecular and structur...

Descripción completa

Detalles Bibliográficos
Autores principales: Miluzio, Annarita, Cuomo, Alessandro, Cordiglieri, Chiara, Donnici, Lorena, Pesce, Elisa, Bombaci, Mauro, Conti, Matteo, Fasciani, Alessandra, Terracciano, Luigi, Manganaro, Lara, Toccafondi, Mirco, Scagliola, Alessandra, Oliveto, Stefania, Ricciardi, Sara, Grifantini, Renata, De Francesco, Raffaele, Abrignani, Sergio, Manfrini, Nicola, Biffo, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795807/
https://www.ncbi.nlm.nih.gov/pubmed/36584595
http://dx.doi.org/10.1016/j.ebiom.2022.104390
_version_ 1784860339044614144
author Miluzio, Annarita
Cuomo, Alessandro
Cordiglieri, Chiara
Donnici, Lorena
Pesce, Elisa
Bombaci, Mauro
Conti, Matteo
Fasciani, Alessandra
Terracciano, Luigi
Manganaro, Lara
Toccafondi, Mirco
Scagliola, Alessandra
Oliveto, Stefania
Ricciardi, Sara
Grifantini, Renata
De Francesco, Raffaele
Abrignani, Sergio
Manfrini, Nicola
Biffo, Stefano
author_facet Miluzio, Annarita
Cuomo, Alessandro
Cordiglieri, Chiara
Donnici, Lorena
Pesce, Elisa
Bombaci, Mauro
Conti, Matteo
Fasciani, Alessandra
Terracciano, Luigi
Manganaro, Lara
Toccafondi, Mirco
Scagliola, Alessandra
Oliveto, Stefania
Ricciardi, Sara
Grifantini, Renata
De Francesco, Raffaele
Abrignani, Sergio
Manfrini, Nicola
Biffo, Stefano
author_sort Miluzio, Annarita
collection PubMed
description BACKGROUND: The COVID-19 pandemic is an infectious disease caused by SARS-CoV-2. The first step of SARS-CoV-2 infection is the recognition of angiotensin-converting enzyme 2 (ACE2) receptors by the receptor-binding domain (RBD) of the viral Spike (S) glycoprotein. Although the molecular and structural bases of the SARS-CoV-2-RBD/hACE2 interaction have been thoroughly investigated in vitro, the relationship between hACE2 expression and in vivo infection is less understood. METHODS: Here, we developed an efficient SARS-CoV-2-RBD binding assay suitable for super resolution microscopy and simultaneous hACE2 immunodetection and mapped the correlation between hACE2 receptor abundance and SARS-CoV-2-RBD binding, both in vitro and in human lung biopsies. Next, we explored the specific proteome of SARS-CoV-2-RBD/hACE2 through a comparative mass spectrometry approach. FINDINGS: We found that only a minority of hACE2 positive spots are actually SARS-CoV-2-RBD binding sites, and that the relationship between SARS-CoV-2-RBD binding and hACE2 presence is variable, suggesting the existence of additional factors. Indeed, we found several interactors that are involved in receptor localization and viral entry and characterized one of them: SLC1A5, an amino acid transporter. High-resolution receptor-binding studies showed that co-expression of membrane-bound SLC1A5 with hACE2 predicted SARS-CoV-2 binding and entry better than hACE2 expression alone. SLC1A5 depletion reduces SARS-CoV-2 binding and entry. Notably, the Omicron variant is more efficient in binding hACE2 sites, but equally sensitive to SLC1A5 downregulation. INTERPRETATION: We propose a method for mapping functional SARS-CoV-2 receptors in vivo. We confirm the existence of hACE2 co-factors that may contribute to differential sensitivity of cells to infection. FUNDING: This work was supported by an unrestricted grant from “Fondazione Romeo ed Enrica Invernizzi” to Stefano Biffo and by AIRC under MFAG 2021 - ID. 26178 project – P.I. Manfrini Nicola.
format Online
Article
Text
id pubmed-9795807
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-97958072022-12-28 Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2 Miluzio, Annarita Cuomo, Alessandro Cordiglieri, Chiara Donnici, Lorena Pesce, Elisa Bombaci, Mauro Conti, Matteo Fasciani, Alessandra Terracciano, Luigi Manganaro, Lara Toccafondi, Mirco Scagliola, Alessandra Oliveto, Stefania Ricciardi, Sara Grifantini, Renata De Francesco, Raffaele Abrignani, Sergio Manfrini, Nicola Biffo, Stefano eBioMedicine Articles BACKGROUND: The COVID-19 pandemic is an infectious disease caused by SARS-CoV-2. The first step of SARS-CoV-2 infection is the recognition of angiotensin-converting enzyme 2 (ACE2) receptors by the receptor-binding domain (RBD) of the viral Spike (S) glycoprotein. Although the molecular and structural bases of the SARS-CoV-2-RBD/hACE2 interaction have been thoroughly investigated in vitro, the relationship between hACE2 expression and in vivo infection is less understood. METHODS: Here, we developed an efficient SARS-CoV-2-RBD binding assay suitable for super resolution microscopy and simultaneous hACE2 immunodetection and mapped the correlation between hACE2 receptor abundance and SARS-CoV-2-RBD binding, both in vitro and in human lung biopsies. Next, we explored the specific proteome of SARS-CoV-2-RBD/hACE2 through a comparative mass spectrometry approach. FINDINGS: We found that only a minority of hACE2 positive spots are actually SARS-CoV-2-RBD binding sites, and that the relationship between SARS-CoV-2-RBD binding and hACE2 presence is variable, suggesting the existence of additional factors. Indeed, we found several interactors that are involved in receptor localization and viral entry and characterized one of them: SLC1A5, an amino acid transporter. High-resolution receptor-binding studies showed that co-expression of membrane-bound SLC1A5 with hACE2 predicted SARS-CoV-2 binding and entry better than hACE2 expression alone. SLC1A5 depletion reduces SARS-CoV-2 binding and entry. Notably, the Omicron variant is more efficient in binding hACE2 sites, but equally sensitive to SLC1A5 downregulation. INTERPRETATION: We propose a method for mapping functional SARS-CoV-2 receptors in vivo. We confirm the existence of hACE2 co-factors that may contribute to differential sensitivity of cells to infection. FUNDING: This work was supported by an unrestricted grant from “Fondazione Romeo ed Enrica Invernizzi” to Stefano Biffo and by AIRC under MFAG 2021 - ID. 26178 project – P.I. Manfrini Nicola. Elsevier 2022-12-28 /pmc/articles/PMC9795807/ /pubmed/36584595 http://dx.doi.org/10.1016/j.ebiom.2022.104390 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Articles
Miluzio, Annarita
Cuomo, Alessandro
Cordiglieri, Chiara
Donnici, Lorena
Pesce, Elisa
Bombaci, Mauro
Conti, Matteo
Fasciani, Alessandra
Terracciano, Luigi
Manganaro, Lara
Toccafondi, Mirco
Scagliola, Alessandra
Oliveto, Stefania
Ricciardi, Sara
Grifantini, Renata
De Francesco, Raffaele
Abrignani, Sergio
Manfrini, Nicola
Biffo, Stefano
Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2
title Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2
title_full Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2
title_fullStr Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2
title_full_unstemmed Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2
title_short Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2
title_sort mapping of functional sars-cov-2 receptors in human lungs establishes differences in variant binding and slc1a5 as a viral entry modulator of hace2
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795807/
https://www.ncbi.nlm.nih.gov/pubmed/36584595
http://dx.doi.org/10.1016/j.ebiom.2022.104390
work_keys_str_mv AT miluzioannarita mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2
AT cuomoalessandro mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2
AT cordiglierichiara mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2
AT donnicilorena mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2
AT pesceelisa mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2
AT bombacimauro mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2
AT contimatteo mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2
AT fascianialessandra mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2
AT terraccianoluigi mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2
AT manganarolara mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2
AT toccafondimirco mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2
AT scagliolaalessandra mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2
AT olivetostefania mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2
AT ricciardisara mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2
AT grifantinirenata mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2
AT defrancescoraffaele mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2
AT abrignanisergio mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2
AT manfrininicola mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2
AT biffostefano mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2